EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanotherapies for Atherosclerosis: Targeting, Catalysis, and Energy Transduction

Yuqi Yang, Jingguo Qu, Tonghuan Xiao, Xinyang Han, Michael Tin-Cheung Ying iD

Advanced Healthcare Materials · 2026-05 · 15 (20)

DOI: 10.1002/adhm.202505792 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 10.03.2026. Verfasst von Yuqi Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China. Hauptthemen laut MEDLINE: Atherosclerosis, Nanomedicine, Nanoparticles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 450 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PolyU Presidential PhD Fellowship Scheme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis (AS), the pathological cornerstone of global cardiovascular mortality, remains inadequately managed by current therapies due to low bioavailability, off‐target effects, and inability to overcome plaque spatial heterogeneity. Nanotechnology solves these limitations through innovative designs that leverage its unique advantages: precise targeting, enhanced pharmacokinetic profile, and intrinsic functionalities. This review systematically examines three core therapeutic strategies: (1) Advanced target‐engineered nanocarriers achieving lesion‐specific precision via ligand modification, biomimetic camouflage, stimuli‐responsive activation, and nanomotor propulsion; (2) Catalytic nanozymes reprogramming plaque microenvironments through intrinsic ROS scavenging and lipid metabolism modulation; (3) Energy‐transducing nanoplatforms enabling physical intervention via photo‐, sono‐, and magnetic therapies. For each seminal study, we critically analyze the design rationale and innovations, elucidate underlying mechanisms, and demonstrate quantitative efficacy. Finally, we discuss the challenges and future directions for nanotherapeutics in AS management. This work provides the first comprehensive integration of material innovation and therapeutic advancement, charting a clinical translation pathway for AS nanomedicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisNanomedicineNanoparticlesHumansCatalysisAnimals

Stichwörter der Autor:innen

active targetingatherosclerosisenergy‐converting nanotherapiesnanotechnologynanozyme

Autor:innen und Institutionen

  • Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China.

ORCID-Profile: Michael Tin-Cheung Ying

Förderung

  • PolyU Presidential PhD Fellowship Scheme

Zitieren

APA

Yang, Y., Qu, J., Xiao, T., Han, X., & Ying, M. T. (2026). Nanotherapies for Atherosclerosis: Targeting, Catalysis, and Energy Transduction. Advanced Healthcare Materials, 15(20). https://doi.org/10.1002/adhm.202505792

Vancouver

Yang Y, Qu J, Xiao T, Han X, Ying MT. Nanotherapies for Atherosclerosis: Targeting, Catalysis, and Energy Transduction. Advanced Healthcare Materials. 2026;15(20). doi:10.1002/adhm.202505792

BibTeX
@article{Yang2026,
  author = {Yang, Yuqi and Qu, Jingguo and Xiao, Tonghuan and Han, Xinyang and Ying, Michael Tin-Cheung},
  title = {Nanotherapies for Atherosclerosis: Targeting, Catalysis, and Energy Transduction},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {20},
  doi = {10.1002/adhm.202505792}
}
Kostenlos starten →